TSX · BLCO.TO
Bausch + Lomb Corporation
CA$28.75+CA$0.19 (+0.67%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 3.3% below the high.
Loading market information…
FSX · 2NU.F · EUR
Stock price
Quote as of May 8, 2023, 06:24 AM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
High Fusion Inc. operates primarily within the cannabis sector, specializing in the creation and manufacturing of branded products. Its diverse range of offerings encompasses dried flower, pre-rolls, vapes, edibles, and concentrated oil extracts, catering to both medical patients and adult recreational users across the United States. The company's brand portfolio includes FLÏ, recognized for its edibles and vape products, alongside OutCo and Thrive. Established in 2004, the enterprise, formerly known as Nutritional High International Inc., officially adopted its current name, High Fusion Inc., in November 2021. Its corporate headquarters are situated in Toronto, Canada.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:18 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
CA$28.75+CA$0.19 (+0.67%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 3.3% below the high.
€0.02€0.00 (0.0%)
BZAM Ltd.’s quoted price sits in the lower half of its reported 52-week range, 88.28% below the high.
€0.13-€0.05 (-27.64%)
Medigene AG’s quoted price sits in the lower half of its reported 52-week range, 96.79% below the high.
€0.87€0.00 (0.0%)
Epigenomics AG’s quoted price sits in the lower half of its reported 52-week range, 45.28% below the high.
$0.00$0.00 (0.0%)
Molecule Holdings Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
€0.05€0.00 (0.0%)
Paion AG’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
€0.02€0.00 (0.0%)
Aladdin Healthcare Technologies SE’s quoted price sits in the lower half of its reported 52-week range, 91.9% below the high.
€0.32€0.00 (0.0%)
CytoTools AG’s quoted price sits in the lower half of its reported 52-week range, 90.93% below the high.
